Source: MarketScreener

Curasan Ag: Xlife Sciences : and curasan form joint venture company to research biosurgical treatment therapies

(marketscreener.com) cMedia Release Zurich, March 21, 2022 Xlife Sciences and curasan form joint venture company to research biosurgical treatment therapies Xlife Sciences AG and curasan AG, a leading global provider of biomaterials for bone and tissue regeneration in dental and...https://www.marketscreener.com/quote/stock/XLIFE-SCIENCES-AG-133157244/news/Xlife-Sciences-and-curasan-form-joint-venture-company-to-research-biosurgical-treatment-therapies-39812866/?utm_medium=RSS&utm_content=20220321

Read full article »
Annual Revenue
$5.0-25M
Employees
25-100
CEO Avatar

CEO

Alexander Baratta

CEO Approval Rating

- -/100

Read more